Skip to main content
editorial
. 2010 Dec 28;2(12):455–462. doi: 10.4329/wjr.v2.i12.455

Figure 5.

Figure 5

Hepatocellular carcinoma showing hyper-enhancing in arterial phase with necrotic non-enhancing areas (A), iso-enhancement in portal venous phase with necrotic non-enhancing areas (B), and hypo/iso-enhancing in late phase (C).